{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-004025","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.628541+00:00","generated_at":"2026-05-27T08:24:58.176145+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intelligent Bio Solutions partners with IVY Diagnostics to expand EU & Middle East drug screening market","bullets":["Partnership with IVY Diagnostics Srl as key distributor for fingerprint drug screening in Europe and Middle East.","IVY Diagnostics secured a tender for drug rehab programs across Italy using INBS' fingerprint drug screening technology.","INBS' drug screening system undergoing trial with Turin police for roadside screening to test fingerprint-based method.","Expansion to multiple countries: Romania, Hungary, Slovakia, Austria, Scandinavia, UAE, Saudi Arabia, Qatar.","European drug screening market projected at $3.6B by 2030; Middle East & Africa at $432.7M (Grand View Research)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-004025","json":"https://secwatch.observer/filing/0001493152-25-004025.json","markdown":"https://secwatch.observer/filing/0001493152-25-004025.md","text":"https://secwatch.observer/filing/0001493152-25-004025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225004025/0001493152-25-004025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225004025/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T08:24:58.176145+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}